<DOC>
	<DOCNO>NCT03047538</DOCNO>
	<brief_summary>The aim study compare effect fix free combination atorvastatin/perindopril/amlodipine blood pressure lipid level .</brief_summary>
	<brief_title>Fixed Combination Lipid Blood Pressure Control</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients uncontrolled arterial hypertension ( average 24h blood pressure range 130/80 180/110 mmHg / daytime average blood pressure range 135/85180/110 mmHg ) one following : 1. high cardiovascular risk LDLcholesterol &gt; 1.8 mmol / l 2. high cardiovascular risk LDLcholesterol &gt; 2.5 mmol / l 3 . Patient high high cardiovascular risk treat lipidlowering therapy statin 1. hypersensitivity perindopril ACE inhibitor , amlodipine , atorvastatin , dihydropyridines statins 2. angioneurotic edema medical history ( hereditary / idiopathic associate prior treatment ACE inhibitor ) 3. severe hypotension , shock , include cardiogenic shock 4. hemodynamically unstable heart failure 5 . Active liver disease unexplained persistent elevation serum transaminase three time normal 6 . Women childbearing age without reliable contraception 7. pregnancy 8. breastfeeding 9 . Patients contraindication list currently valid SP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Arterial hypertension</keyword>
	<keyword>Dyslipidemia</keyword>
	<keyword>Blood pressure control</keyword>
	<keyword>Fixed combination</keyword>
</DOC>